Intrahepatic Cholangiocarcinoma (Icc)
Oncology·MeSH: Cholangiocarcinoma
Prevalence
2.5 / 100K
Incidence
1.3 / 100K/yr
2 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Intrahepatic Cholangiocarcinoma (Icc)?
BioSniper tracks 2 drugs in development for Intrahepatic Cholangiocarcinoma (Icc) across 2 companies.
How many clinical trials target Intrahepatic Cholangiocarcinoma (Icc)?
There are 3 clinical trials targeting Intrahepatic Cholangiocarcinoma (Icc) tracked by BioSniper.
What is the prevalence of Intrahepatic Cholangiocarcinoma (Icc)?
The estimated prevalence of Intrahepatic Cholangiocarcinoma (Icc) is approximately 2.5 per 100,000 population.
Deep-dive into Intrahepatic Cholangiocarcinoma (Icc)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis